Randomised Double Blind, Controlled, Parallel Group, Multicentre Study of a Subcutaneous Formulation of Icatibant Versus Oral Tranexamic Acid for the Treatment of Hereditary Angioedema (HAE).
Phase of Trial: Phase III
Latest Information Update: 19 Feb 2015
At a glance
- Drugs Icatibant (Primary) ; Tranexamic acid
- Indications Hereditary angioedema
- Focus Therapeutic Use
- Acronyms FAST-2
- Sponsors Shire
- 12 Sep 2013 Results published in Allergy.
- 08 Apr 2009 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History